论文-万方医学网

1. Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.

【外文期刊】 Brian,Chen ; Sumimasa,Nagai ; 等《The oncologist》 2019年24卷4期 537-548页 SCIMEDLINE

【关键词】 Biologics; Biosimilars; Chemotherapy;

OA

浏览：15 被引：0 下载：0

2. Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.

【外文期刊】 Charles L,Bennett ; Martin W,Schoen ; 等《The Lancet. Oncology》 2020年21卷12期 e575-e588页 SCIMEDLINE

原文传递

浏览：2 被引：0 下载：0

3. End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia.

【外文期刊】 Shamia,Hoque ; Brian J,Chen ; 等《PloS one》 2020年15卷6期 e0234541页 SCIMEDLINECABP

OA

浏览：2 被引：0 下载：0

4. End of an era for erythropoiesis-stimulating agents in oncology.

【外文期刊】 Martin W,Schoen ; Shamia,Hoque ; 等《International journal of cancer》 2020年146卷10期 2829-2835页 SCIMEDLINECABP

【关键词】 adverse events; deimplementation; erythropoeitin;

原文传递

浏览：0 被引：0 下载：0

5. Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions.

【外文期刊】 Charles L,Bennett ; Benjamin,Schooley ; 等《PloS one》 2019年14卷7期 e0219521页 SCIMEDLINECABP

OA

浏览：2 被引：0 下载：0

6. Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997-2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR).

【外文期刊】 Charles L,Bennett ; Shamia,Hoque ; 等《EClinicalMedicine》 2021年31卷 100693页

【关键词】 Adverse drug reaction; Liability; Patient harm;

LinkOut

浏览：0 被引：0 下载：0

7. Response to: letter to the editor: consideration on 'an evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the food and drug administration and the European medicines agency' by bennett et al.

【外文期刊】 Andrew C,Bennett ; Charles L,Bennett ; 等《Expert opinion on drug safety》 2020年19卷8期 1057-1058页 SCIMEDLINE

【关键词】 Fibrosis; cell culture; experimental models;

OA

浏览：4 被引：0 下载：0

8. An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency.

【外文期刊】 Andrew C,Bennett ; Charles L,Bennett ; 等《Expert opinion on drug safety》 2019年18卷11期 1055-1063页 SCIMEDLINE

【关键词】 Fluoroquinolones; REMS (Risk Evaluation and Mitigation Strategy); adverse events;

OA

浏览：14 被引：0 下载：0

9. Response to: letter to the editor: consideration on 'an evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the food and drug administration and the European medicines agency' by bennett et al

【外文期刊】 Bennett, Andrew C. ; Bennett, Charles L. ; 等 2020年19卷7/12期 1057-1057页 SCISCIEMEDLINE

【关键词】 Fibrosis; experimental models; cell culture;

原文传递

浏览：0 被引：0 下载：0

检索历史清除

模糊

与

模糊

与

模糊

开始

结束

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

模糊

与

模糊

与

模糊

开始

结束

批量导出

批量导出

检索历史清除